课题基金 / 基金详情

37th Annual International Narcotics Research Conference

37th Annual International Narcotics Research Conference
第 37 届国际麻醉品研究年度会议
批准号:
7167690
负责人:
JEAN M BIDLACK
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30

项目摘要

项目成果

JEAN M BIDLACK的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):要求支持将于2006年7月9日至14日在明尼苏达州圣保罗举行的第37届国际麻醉品研究会议(INRC)。国际药物研究中心多年来一直是传播和交流关于阿片类药物和内源性阿片类系统生物医学研究信息的最负盛名的国际会议。主题范围从分子到行为和临床研究。虽然主要主题仍然是阿片类药物和滥用,但由于这些药物与内源性阿片系统之间的广泛相互作用已被记录,因此对大麻、可卡因、安非他明和酒精等其他滥用药物的讨论也越来越多。所要求的支助主要是部分旅费支助,以使青年科学家,即研究生、博士后研究员和初级教员能够参加会议。资金的一小部分将支持来自与成瘾药物研究有关的其他学科的杰出全体会议发言人,他们将介绍可能对国际药物研究中心听众有用的战略、概念或技术。受邀的研讨会发言人,通常不是INRC的参与者,将得到部分支持。要求用于行政和会议费用的资金约占总数的15%。今年,国际研究中心有五位确认的全体会议发言人就不同的主题,包括博士。埃默里大学的Gary Bessell,伊利诺伊大学的Jonathan Sweedler和约翰霍普金斯大学的Paul Worley。Drs。来自密歇根大学的Huda Akil和Stan Watson被选为2006年会议的创始人讲师。八个专题讨论会将涵盖应用程序中描述的广泛主题,包括蛋白质组学和药物滥用,奖励导向行为的遗传见解,阿片受体基因的调节,阿片样物质作为细胞死亡和生存的调节剂,阿片样物质和压力,阿片样物质,HIV-1和机会性感染。将在每次研讨会上选择一些相关的论文进行口头报告。我们将举办三场海报会议,在这三场会议上,我们会有很多的交流和讨论。将有一个关于NIDA更新和拨款写作的研讨会。对于许多国家的与会者来说,这次国际会议是他们见面交流的唯一机会。我们认为,许多博士前和博士后受训者的参与已经并可能继续导致招募有前途的科学家从事药物滥用研究。
英文摘要
DESCRIPTION (provided by applicant): Support is requested for the 37th annual meeting of the International Narcotics Research Conference (INRC) to be held in St. Paul, Minnesota from July 9-14, 2006. INRC has for many years been the most prestigious international meeting for the dissemination and exchange of information about biomedical research on opiate drugs and the endogenous opioid system. The topics range from molecular to behavioral and clinical studies. While the main topic is still opiate drugs and abuse, there is increasing discussion of other abused drugs, such as marijuana, cocaine, amphetamines, and alcohol, since extensive interactions between these drugs and the endogenous opioid system has been documented. Support is requested primarily for partial travel support to enable young scientists, i.e., graduate students, postdoctoral fellows, and junior faculty, to participate in the Conference. A small portion of funds will support distinguished plenary speakers from other disciplines, relevant to research on addictive drugs, who will describe strategies, concepts or techniques likely to be useful to an INRC audience. Invited symposium speakers, not normally INRC participants, will receive partial support. Funds requested for administrative and meeting expenses represent about 15% of the total. This year, INRC has five confirmed plenary speakers on various topics, including Drs. Gary Bessell, Emory University, Jonathan Sweedler, University of Illinois, and Paul Worley, Johns Hopkins University. Drs. Huda Akil and Stan Watson from the Univ. of Michigan were elected the Founders' Lecturer for the 2006 Meeting. Eight symposia will cover a wide range of topics described in the application, including proteomics and drug abuse, genetic insights into reward-directed behaviors, regulation of opioid receptor genes, opioids as modulators of cell death and survival, opioids and stress, and opioids, HIV-1 and opportunistic infections. A number of relevant contributed papers will be chosen for oral presentation at each symposium. There will be three poster sessions, at which there is always much exchange and discussion. There will be a workshop on NIDA updates and grant writing. For participants from many countries, this international meeting is their only chance to meet and exchange ideas. We feel that participation by many pre- and post-doctoral trainees has resulted and is likely to continue to result in recruiting promising scientists to a career of drug abuse research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
G alpha Z subunit as a potential therapeutic target to modulate mu opioid receptor pharmacology
  • 批准号:
    10580415
  • 项目类别:
  • 资助金额:
    $42.35万
  • 财政年份:
    2022
  • 负责人:
    JEAN M BIDLACK
  • 依托单位:
38th Annual International Narcotics Research Conference
36th Annual International Narcotics Research Conference
Opioid Binding to U51: A Human herpes Virus Protein
  • 批准号:
    6447741
  • 项目类别:
  • 资助金额:
    $15.95万
  • 财政年份:
    2001
  • 负责人:
    JEAN M BIDLACK
  • 依托单位: